Ginkgo Bioworks’ Enzyme Services selected by Ensovi for biomanufacturing

Ginkgo Bioworks announced a new partnership with Ensovi, which has invented an efficient, cell-free biomanufacturing platform that transforms waste CO2 to organic chemicals. Ensovi will leverage Ginkgo Enzyme Services to help optimize its platform for the cell-free transformation of carbon dioxide into Acetyl-CoA, which can then be converted into many other products, such as precursors to flavorings, supplements, pharmaceuticals or even fuels, using Ensovi’s end-to-end, cell-free biosynthesis approach. Under the terms of the agreement, Ginkgo will support the discovery and development of enzymes needed to bring Ensovi’s cell-free biomanufacturing platform to market. Ginkgo Enzyme Services offers partners end-to-end support for the discovery, engineering, optimization, and scale-up of enzymes for diverse applications.